Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study

2016, Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants, Lancet, 387, 1513, 10.1016/S0140-6736(16)00618-8 2016, Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants, Lancet, 387, 1377, 10.1016/S0140-6736(16)30054-X Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Dulai, 2017, Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis, Hepatology, 65, 1557, 10.1002/hep.29085 Cholankeril, 2017, Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States, Clin Gastroenterol Hepatol Williams, 2018, Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK, Lancet, 391, 1097, 10.1016/S0140-6736(17)32866-0 Newsome, 2012, Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis, Gut, 61, 484, 10.1136/gutjnl-2011-300886 Cholankeril, 2017, Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes, Dig Dis Sci, 62, 2915, 10.1007/s10620-017-4684-x Wong, 2014, Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S., Hepatology, 59, 2188, 10.1002/hep.26986 Charlton, 2011, Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States, Gastroenterology, 141, 1249, 10.1053/j.gastro.2011.06.061 Houlihan, 2011, Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens?, Liver Transplant, 17, 1292, 10.1002/lt.22382 Karam, 2003, Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers, Transplantation, 75, 2167, 10.1097/01.TP.0000080271.20145.07 van der Meulen, 2003, Assessing the quality of the data in a transplant registry: the European Liver Transplant Registry, Transplantation, 75, 2164, 10.1097/01.TP.0000080272.48725.8D Adam, 2012, Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR), J Hepatol, 57, 675, 10.1016/j.jhep.2012.04.015 Wong, 2015, Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States, Gastroenterology, 148, 547, 10.1053/j.gastro.2014.11.039 Younossi, 2015, Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009, Hepatology, 62, 1723, 10.1002/hep.28123 Afzal, 2016, Change in body mass index associated with lowest mortality in Denmark, 1976–2013, JAMA, 315, 1989, 10.1001/jama.2016.4666 NHS Blood and Transplant, NHS England. Annual Report on Liver Transplantation: Report for 2013/2014 2018;2018. https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/12250/nhsbt-liver-transplantation-annual-report-2017-2018.pdf (accessed February 19, 2019). Holmer, 2018, Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries, Liver Int, 38, 2082, 10.1111/liv.13751 Wang, 2014, Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis, Clin Gastroenterol Hepatol, 12, 10.1016/j.cgh.2013.09.023 Goldberg, 2017, Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation, Gastroenterology, 152, 10.1053/j.gastro.2017.01.003 Pineda, 2018, Forecasting future trends in obesity across Europe: the value of improving surveillance, Obes Facts, 11, 360, 10.1159/000492115 Blundell, 2017, Variations in the prevalence of obesity among european countries, and a consideration of possible causes, Obes Facts, 10, 25, 10.1159/000455952 Whiteford, 2013, Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010, Lancet, 382, 1575, 10.1016/S0140-6736(13)61611-6 Thuluvath, 2017, Is cryptogenic cirrhosis different from NASH cirrhosis?, J Hepatol, 68, 519, 10.1016/j.jhep.2017.11.018 Younossi, 2018, Non-alcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates, Clin Gastroenterol Hepatol Dyson, 2014, Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team, J Hepatol, 60, 110, 10.1016/j.jhep.2013.08.011 De Minicis, 2014, HCC development is associated to peripheral insulin resistance in a mouse model of NASH, PLoS One, 9, 10.1371/journal.pone.0097136 Berentzen, 2014, Body mass index in childhood and adult risk of primary liver cancer, J Hepatol, 60, 325, 10.1016/j.jhep.2013.09.015 Wang, 2012, Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis, Diabetes Metab Res Rev, 28, 109, 10.1002/dmrr.1291 Valery, 2018, Projections of primary liver cancer to 2030 in 30 countries worldwide, Hepatology, 67, 600, 10.1002/hep.29498 Daniel, 2017, Why do patients die after a liver transplantation?, Clin Transplant, 31, 10.1111/ctr.12906 Ferla, 2019, Comment on the article “Age and liver transplantation”, J Hepatol, 70, 1305, 10.1016/j.jhep.2019.02.007 van Vugt, 2018, A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort, J Hepatol, 68, 707, 10.1016/j.jhep.2017.11.030 VanWagner, 2015, Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis, Liver Int, 35, 2575, 10.1111/liv.12872 Macdonald, 2015, Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5, Clin Transplant, 29, 506, 10.1111/ctr.12542 Pommergaard, 2018, Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry, HPB, 20, 768, 10.1016/j.hpb.2018.03.002